59 related articles for article (PubMed ID: 8572572)
41. Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.
Pantazis P; Mendoza J; DeJesus A; Early J; Shaw M; Giovanella BC
Anticancer Drugs; 1994 Aug; 5(4):473-9. PubMed ID: 7949254
[TBL] [Abstract][Full Text] [Related]
42. Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line.
Kubiliūtė R; Šulskytė I; Daniūnaitė K; Daugelavičius R; Jarmalaitė S
Medicina (Kaunas); 2016; 52(5):298-306. PubMed ID: 27746118
[TBL] [Abstract][Full Text] [Related]
43. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients.
Kobayashi D; Watanabe N; Yamauchi N; Tsuji N; Sato T; Niitsu Y
Blood; 1997 Apr; 89(7):2472-9. PubMed ID: 9116291
[TBL] [Abstract][Full Text] [Related]
44. Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow.
Kühl JS; Durán GE; Chao NJ; Sikic BI
Cancer Chemother Pharmacol; 1993; 33(1):10-6. PubMed ID: 8269583
[TBL] [Abstract][Full Text] [Related]
45. [Attempt at therapy of leukemia cells with induction of differentiation].
Hozumi M
Hokkaido Igaku Zasshi; 1981 May; 56(3):361. PubMed ID: 7319457
[No Abstract] [Full Text] [Related]
46. Ikaros expression sensitizes leukemic cells to the chemotherapeutic drug doxorubicin.
He L; Gao S; Zhu Z; Chen S; Gu H
Oncol Lett; 2016 Aug; 12(2):1178-1182. PubMed ID: 27446415
[TBL] [Abstract][Full Text] [Related]
47. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
49. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
D'Alessandro N; Flugy A; Tolomeo M; Dusonchet L
Anticancer Res; 1998; 18(4C):3065-72. PubMed ID: 9713511
[TBL] [Abstract][Full Text] [Related]
50. Monocytic differentiation and synthesis of proteins associated with apoptosis in human leukemia U-937 cells acquiring resistance to vincristine.
Pantazis P; Chatterjee D; Han Z; Wyche J; DeJesus A; Giovanella B
Eur J Haematol; 1996 Jul; 57(1):79-86. PubMed ID: 8698136
[TBL] [Abstract][Full Text] [Related]
51. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells.
Kik K; Wasowska-Lukawska M; Oszczapowicz I; Szmigiero L
Anticancer Res; 2009 Apr; 29(4):1429-33. PubMed ID: 19414398
[TBL] [Abstract][Full Text] [Related]
52. Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs.
Pantazis P; Dejesus A; Early J; Rodriguez R; Chatterjee D; Han Z; Wyche J; Giovanella B
Anticancer Res; 1995; 15(5B):1873-81. PubMed ID: 8572572
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
